Cytoreductive treatment patterns for essential thrombocythemia in Europe. Analysis of 3643 patients in the EXELS study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cytoreductive treatment patterns for essential thrombocythemia in Europe. Analysis of 3643 patients in the EXELS study

Published:2013-02 Issue:2 Volume:37 Page:162-168
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Besses Carlos,Kiladjian Jean-Jacques,Griesshammer Martin,Gugliotta Luigi,Harrison Claire,Coll Ruth,Smith Jonathan,Abhyankar Brihad,Birgegård Gunnar

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference29 articles.

1. WHO classification of tumours of haemopoietic and lymphoid tissues;Swerdlow,2008

2. Myeloproliferative disorders: complications, survival and causes of death;Brodmann;Ann Hematol,2000

3. Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia;Passamonti;Am J Med,2004

4. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study;Barbui;J Clin Oncol,2011

5. Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet;Barbui;J Clin Oncol,2011

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group;Clinical and Experimental Medicine;2023-09-25

2. Anagrelide in essential thrombocythemia: Efficacy and long-term consequences in young patient population;Leukemia Research;2022-12

3. A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naïve, high-risk essential thrombocythemia as a primary treatment;Frontiers in Oncology;2022-11-23

4. Anagrelide-associated Cardiomyopathy and Heart Failure in a Patient with Essential Thrombocythemia: A Case Report and Literature Review;Internal Medicine;2022-11-01

5. Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs;Blood Advances;2022-09-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3